Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.39 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.36 |
| ▸ | PKM | P14618 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3248358 | 0.90 | ALDH1A1 (0.38) | ALDH1A1CYP2C19P2RX7PKMLMNA | |
| SCHEMBL3257493 | 0.90 | ALDH1A1 (0.38) | ALDH1A1CYP2C19P2RX7PKMLMNA | |
| SCHEMBL3254057 | 0.89 | TP53 (0.42) | P2RX7TP53ATML3MBTL1MAPT | |
| SCHEMBL3258335 | 0.88 | ALDH1A1 (0.38) | ALDH1A1CYP2C19P2RX7PKMLMNA | |
| SCHEMBL3249024 | 0.87 | KMT2A (0.41) | ALDH1A1CYP2C19P2RX7LMNA | |
| SCHEMBL3255000 | 0.86 | P2RX7 (0.43) | ALDH1A1P2RX7PKMTP53LMNA | |
| SCHEMBL3255413 | 0.85 | ALDH1A1 (0.38) | ALDH1A1CYP2C19P2RX7PKMTP53 | |
| SCHEMBL3256724 | 0.84 | P2RX7 (0.39) | ALDH1A1CYP2C19P2RX7PKMLMNA | |
| SCHEMBL3251176 | 0.83 | ALDH1A1 (0.35) | ALDH1A1CYP2C19P2RX7LMNAPAX8 | |
| SCHEMBL3257729 | 0.83 | ALDH1A1 (0.40) | ALDH1A1CYP2C19P2RX7PKMLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1651613-B1 | 4,5-DIHYDRO-IMIDAZOLE AS P2X7 ION CHANNEL BLOCKERS | AVENTIS PHARMA INC (US) | 2010-05-26 | — | — | EP | disclosed |